T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Breast cancer patients who interrupted endocrine therapy to pursue pregnancy did not have worse short-term recurrence rates

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Updates from TAILORx and RxPONDER: Implications for practice

Maximising cancer treatment and research through omics, data sharing, and open science

Epidemiology, detection, and management of NAFLD: a Latin American perspective

Optimisation of supportive, palliative and end of life care

What is required to advance data ethics, data sharing, and Open Science across LMICs

Access to Oncology Medicines Coalition - The Medicines Patent Pool

UICC / WHO Policy dialogue: Maintaining cancer care in times of conflict and environmental emergencies

Cancer and conflict in the Middle East: Syria, Lebanon and Palestine